146 related articles for article (PubMed ID: 18163942)
1. Options and recent advances in permanent brachytherapy for prostate cancer.
Marshall DT
Can J Urol; 2007 Dec; 14 Suppl 1():28-31. PubMed ID: 18163942
[TBL] [Abstract][Full Text] [Related]
2. Initial comparison of inverse optimization, modified peripheral technique, and geometric optimization as real-time intraoperative computer planning options for permanent seed implantation of the prostate.
Raben A; Sammons S; Sim S; Chen H; Hanlon A; Sarkar A; Donavanik V; Grebler A; Geltzeiler J; Benge B; Glick A; Jacob D; Koprowski P
Brachytherapy; 2007; 6(4):238-45. PubMed ID: 17991621
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
4. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy.
Polo A; Salembier C; Venselaar J; Hoskin P;
Radiother Oncol; 2010 Jan; 94(1):12-23. PubMed ID: 20074822
[TBL] [Abstract][Full Text] [Related]
5. 4D Brachytherapy, a novel real-time prostate brachytherapy technique using stranded and loose seeds.
Langley SE; Laing RW
BJU Int; 2012 Feb; 109 Suppl 1():1-6. PubMed ID: 22239223
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
7. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy for carcinoma of the prostate: techniques, patient selection, and clinical outcomes.
Blasko JC; Mate T; Sylvester JE; Grimm PD; Cavanagh W
Semin Radiat Oncol; 2002 Jan; 12(1):81-94. PubMed ID: 11813153
[TBL] [Abstract][Full Text] [Related]
9. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric guidance on using brachytherapy (low-dose-rate or high-dose-rate) to offset a flawed permanent prostate implant.
Zaider M
Brachytherapy; 2009; 8(1):40-4. PubMed ID: 19058764
[TBL] [Abstract][Full Text] [Related]
11. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
Stone NN; Potters L; Davis BJ; Ciezki JP; Zelefsky MJ; Roach M; Shinohara K; Fearn PA; Kattan MW; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):341-6. PubMed ID: 18597953
[TBL] [Abstract][Full Text] [Related]
12. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract][Full Text] [Related]
13. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
Klein EA; Ciezki J; Kupelian PA; Mahadevan A
Urol Oncol; 2009; 27(1):67-71. PubMed ID: 19111801
[TBL] [Abstract][Full Text] [Related]
14. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
15. [Permanent implant prostate cancer brachytherapy].
Cosset JM; Flam T; Thiounn N; Pontvert D; Pierrat N; Vallancien G; Chauveinc L
Cancer Radiother; 2008 Nov; 12(6-7):503-11. PubMed ID: 18829365
[TBL] [Abstract][Full Text] [Related]
16. A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment.
Strigari L; Orlandini LC; Andriani I; d'Angelo A; Stefanacci M; Di Nallo AM; Benassi M
Phys Med Biol; 2008 Sep; 53(18):5045-59. PubMed ID: 18723926
[TBL] [Abstract][Full Text] [Related]
17. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
[TBL] [Abstract][Full Text] [Related]
18. Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its application.
Sahgal A; Roach M
Nat Clin Pract Urol; 2007 Dec; 4(12):658-70. PubMed ID: 18059346
[TBL] [Abstract][Full Text] [Related]
19. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer.
Morris WJ; Keyes M; Palma D; Spadinger I; McKenzie MR; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Berthelet E; Pai H
Urology; 2009 Apr; 73(4):860-5; discussion 865-7. PubMed ID: 19168203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
